Your Messages Inbox
Your Article Summary
See Latest ArticlesPharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes
The European Journal of Health Economics, 08/04/09
Lee YC et al. – Hospital characteristics and volume of services determined the concentration of pharmaceuticals at the institution level, reflecting the heterogeneous competition between pharmaceutical companies within each hospital. Institution–level pharmaceutical concentration influences the adoption and penetration of new drugs.
Related Articles
Takeda to Establish Four Sales and Marketing Subsidiaries to Expand its Operations in Mexico, Turkey and Five Other Countries in Europe
Takeda Pharmaceuticals North America, 10/02/09
Relevance Score: 46%
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
Amylin Pharmaceuticals, 11/02/09
Relevance Score: 45%
30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
PharmacoEconomics, 10/13/09
Relevance Score: 45%
APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09
Relevance Score: 45%
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Cephalon, 10/28/09
Relevance Score: 43%
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09
Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Article Search
Sponsor